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Endoscopy is essential for diagnosis and treatment of cancers derived from 
gastrointestinal tract. However, conventional white light image has technical limitation 
in detecting small or superficial lesions. Narrow band imaging, especially with 
magnification, allows visualize a microstructure pattern and microvascular patterns in 
the mucosal surface. These technical breakthroughs enable endoscopists to easily detect 
small pre-neoplastic and neoplastic lesions and to make differential diagnosis of these 




Narrow-band imaging is discussed, which allows endoscopists to easily diagnose small 
lesions and to make differential diagnosis of these lesions. Appropriate diagnosis with 
NBI contributes to minimally invasive treatments. 
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NARROW BAND IMAGING 
 
Narrow band imaging (NBI) is an innovative optical technology that allows the distinct 
visualization of microsurface patterns and microvascular patterns on the mucosal 
surface (1-3). The NBI system uses narrow-band illumination created with optical 
interference filters that generate 415 nm and 540 nm wavelengths, corresponding to the 
peaks of absorption of hemoglobin. Therefore, thin blood vessels, such as capillaries, in 
the epithelium or mucosal layer can be seen more distinctly than in a conventional 
white-light image (WLI) (Figure 1).  
Currently, two types of image reconstruction systems are used for endoscopic imaging: 
a red–green–blue (RGB) time sequential illumination system with a monochrome 
charge-coupled device (CCD) and white-light illumination with a color chip CCD. The 
NBI system is applicable to both systems by placing the narrow-band light filter in front 
of the light source. NBI can provide the same clinical benefits with both illumination 
systems (Table 1), although the color reproduction and the image resolution are 




HEAD AND NECK REGION 
 
HEAD AND NECK CANCER 
Lugol chromoendoscopy is the standard method for detecting early squamous cell 
carcinoma (SCC) of the esophagus. However, Lugol dye solution cannot be applied to 
the oropharynx or hypopharynx because of the risk of aspiration. Moreover, the image 
resolution of rhinolaryngoscopy does not effectively identify superficial neoplastic 
lesions in the head and neck region. Therefore, the early detection of cancers in the 
oropharynx and hypopharynx has been difficult. This is partly attributable to the 
technological limitations in mounting a high-resolution CCD on the tip of a 
rhinolaryngoscope. 
Muto et al. first reported the utility of NBI combined with magnifying endoscopy 
(Q240Z, Olympus Medical Systems, Tokyo, Japan) in the identification of superficial 
SCCs in the head and neck region (5). Compared with WLI, NBI significantly improved 
the visualization of the cancerous lesions by enhancing the contrast between the 
cancerous lesion and the background nonneoplastic epithelium, and by the clear 
magnification of the microvascular architecture (6). Muto et al. reported that the 
well-demarcated brownish areas observed under NBI and the microvascular 
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irregularities visible under magnification with NBI were useful indicators of cancerous 
lesions in the head and neck region (1). In the multicenter prospective randomized study, 
NBI is revealed to be superior to WLI in the detection and differential diagnosis for 
superficial head and neck cancer (7). 
Watanabe et al. reported that the NBI rhinolaryngoscope (ENF-V2, Olympus Medical 
Systems) with a color-chip light source (CLV-160B, Olympus Medical Systems) 
improved the diagnostic accuracy, and the negative predictive values for superficial 
lesions in the oropharynx and hypopharynx compared with those of conventional WLI 
(8, 9). However, there is still a critical difference in the image qualities of CCDs 
between the gastrointestinal endoscopy and that the rhinolaryngoscope.  
Ugumori et al. prospectively compared the images taken with a color-chip-based 
rhinolaryngoscope and those taken with an RGB-sequential-system-based 
high-resolution gastrointestinal endoscope (10). Whereas the conventional white-light 
rhinolaryngoscope identified well-demarcated line between the neoplastic and 
nonneoplastic lesions in only 10% (5/51) of cases and microvascular irregularities in 
only 27% (14/51), the NBI rhinolaryngoscope identified these in 63% (32/51) and 94% 
(49/51) of cases, respectively. These results indicate that even with a rhinolaryngoscope, 
NBI can improve the visualization of epithelial neoplasms of the head and neck region. 
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When combined with a high-definition television camera (HDTV), the effectiveness of 
NBI is improved in terms of both its sensitivity and specificity.(11) 
NBI is also reportedly useful in detecting metachronous SCC after treatment for 
esophageal SCC (chemoradiotherapy, radiation therapy, or surgery), and unknown 
primary SCC of the neck, and adenoid hypertrophy (12-18) (Table 1). 
The early detection of cancer in this region increases the possibility of minimally 
invasive surgery, including endoscopic mucosal resection and endoscopic submucosal 
dissection methods (19, 20). The potential advantages to patients resulting from an early 




ESOPHAGEAL SQUAMOUS CELL CARCINOMA 
Although the early detection of cancer offers the best prognosis, many esophageal SCCs 
(ESCCs) are still detected at a late stage, with a consequently poor prognosis. One 
reason is that the early detection of ESCC is difficult using conventional WLI 
endoscopy because it cannot identify the morphological changes of superficial ESCC. 
Although Lugol chromoendoscopy is the sanistive method for the detection of early 
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superficial ESCC (Figure1 A, B), iodine is an irritant and causes unpleasant reactions, 
such as pain, discomfort and sometimes allergic reaction. In contrast, NBI is less 
invasive than Lugol chromoendoscopy and enhances the clarity of the intrapapillary 
capillary loop (IPCL) patterns beneath the epithelium (5, 21, 22), so it is expected to 
replace Lugol chromoendoscopy in this role (Figure1 C,D). 
Using an ultrathin endoscope (5 mm in diameter at the distal end; XP260N, Olympus 
Medical Systems), Lee et al. reported the utility of NBI in the detection and accurate 
diagnosis of ESCC (23). The sensitivity of NBI was significantly better than that of 
conventional WLI. The specificity and positive predictive value of NBI were also better 
than those of Lugol chromoendoscopy, whereas their diagnostic accuracy and negative 
predictive value were similar. These results suggest that, even when an ultrathin 
endoscope is used, NBI is the best tool for screening for superficial esophageal 
neoplasms, as in the head and neck region. 
In a multicenter prospective randomized study (7), NBI with a standard-diameter 
endoscope showed approximately twofold greater sensitivity than WLI. Furthermore, 
most of the Lugol-voiding lesions overlooked by NBI endoscopy were low grade 
intraepithelial neoplasia or lesions without atypical findings (24).  
In 2011, a new classification of magnified endoscopy for superficial ESCC was 
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proposed by Japan Esophageal Society (2d5), which allows the differential diagnosis of 
ESCC, intraepithelial neoplasia, and inflammation. This classification is expected to 
simplify the diagnosis and evaluation of the depth of invasion of superficial ESCCs. 
 
GASTROESOPHAGEAL REFLUX DISEASE (GERD) 
GERD is defined by the presence of reflux esophagitis. When it causes reflux symptoms 
(chest pain, heartburn, discomfort, etc.), the patient’s quality of life is adversely affected 
(26). Moreover, a significant number of patients with GERD symptoms show no 
endoscopic signs of esophagitis. This condition is described as “nonerosive reflux 
disease” (NERD). Many NERD patients show minimal endoscopic findings, such as a 
whitish or reddish edematous change or erosion that is not regarded as a mucosal break 
(27). These minimal changes are potentially related to various GERD symptoms (28). 
However, the interobserver agreement when NERD is diagnosed with conventional 
WLI is reportedly too low to support the clinical significance of this technique (29). In 
contrast, NBI is expected to overcome this limitation, because it allows the visualization 
of the superficial and slight findings attributable to NERD, which cannot be seen with 
conventional WLI. 
Lee et al. reported that the intraobserver and interobserver consistencies in grading 
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esophagitis improved when NBI was used instead of WLI (30). Sharma et al. reported a 
feasibility study of magnified endoscopy with NBI in patients with GERD (31). They 
showed that increased numbers and the dilatation of IPCLs were the best predictors of a 
diagnosis of GERD, with moderate to high interobserver agreement. 
 
BARRETT’S ESOPHAGUS AND CANCER 
The incidence of esophageal adenocarcinoma is increasing in Western countries (32) 
and Barrett’s esophagus (BE) is a precursor lesion of this malignancy. Surveillance of 
BE using WLI with random four-quadrant biopsies is the accepted practice and is 
recommended by the American Gastroenterological Association statement (33). Sharma 
et al. (34) showed in a randomized, controlled, international, crossover trial that the 
success of NBI in detecting intestinal metaplasia did not differ from that of the currently 
accepted practice of random biopsies, but required significantly fewer biopsies. 
Because esophageal adenocarcinoma has a poor prognosis when detected at an 
advanced stage, endoscopic surveillance is recommended to detect high-grade dysplasia 
and mucosal neoplasia in patients with BE. However, it is difficult to identify these 
lesions with conventional WLI. NBI with magnifying endoscopy allows us to visualize 
the details of the mucosal microsurface pattern and the microvascular pattern without 
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additional equipment or dye solutions (35). 
Hamamoto et al. first reported that NBI could better visualize the esophagogastric 
junction, net-like capillary vessels, and columnar-lined esophagus (seen in BE) than 
conventional WLI (36). Kara et al. reported that indigo carmine chromoendoscopy and 
NBI were similarly effective in the diagnosis of high-grade dysplasia or early cancer in 
BE (37). Wolfsen et al. (38) reported that high-resolution NBI can detect dysplastic 
lesions more efficiently, with fewer biopsy samples, than standard-resolution WLI. 
Singh et al. (39) reported that NBI with magnification is superior to WLI with 
magnification in the prediction of histology in BE. 
A recent meta-analysis (40) that included 446 patients with 2194 lesions reported that 
NBI with magnification shows high diagnostic precision in detecting high-grade 
dysplasia, with a sensitivity and specificity of 96% and 94%, respectively. 
 
Stomach 
DETECTION OF GASTRIC NEOPLASM BY NBI  
In the stomach, NBI has been considered to be used with magnification for detailed 
examinations. Because the light intensity under the NBI filter is low, a non-magnified 
image becomes dark compared with that produced under WLI. Furthermore, because 
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the image becomes noisy with the electrical enhancement used to keep the endoscopic 
image bright, it is insufficient to observe the wide area of the stomach. There is also, as 
yet, no evidence that NBI is superior to WLI in detecting early gastric neoplasms. To 
overcome these limitations, much brighter NBI system with higher resolution will be 
commercially available when this review is published. Then, the evidence of other 
clinical benefit of NBI such as detection will be expected in future. 
 
DIFFERENTIAL DIAGNOSIS OF GASTRIC CANCER  
Yao et al. originally reported unique magnifying endoscopic findings of gastric cancer 
in 2002 (41). This marked the beginning of the era of using magnifying endoscopy for 
the diagnosis of gastric cancer. The utility of magnifying endoscopic observations 
combined with WLI for the differential diagnosis of flat or slightly depressed gastric 
cancers and nonneoplastic lesions, such as gastritis, has been reported. NBI combined 
with magnifying endoscopy (magnifying NBI) provides better visualization of the 
mucosal surface and microvascular architecture than magnifying WLI (42). Several 
reports have compared the diagnostic yield of magnifying NBI with that of magnifying 
or nonmagnifying WLI in distinguishing small gastric cancers from the flat or depressed 
benign lesions caused by chronic gastritis (43-45). However, all those reports had some 
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limitations: they were performed at only one institution, evaluated stored images and 
did not involve real-time assessment, or included gastric lesions with a definite 
pathological diagnosis. To overcome these limitations, Ezoe et al. performed a 
multicenter, prospective, randomized, controlled trial that targeted newly detected, 
undiagnosed lesions to compare and evaluate the diagnostic yields of magnifying NBI 
and conventional WLI. The trial revealed that magnifying NBI, especially after 
nonmagnifying WLI, showed an extremely high diagnostic performance (46). 
These lines of evidence suggest that magnifying NBI is currently one of the standard 
endoscopic modalities in the differential diagnosis of gastric cancers. 
 
DETERMINATION OF THE LATERAL EXTENT OF GASTRIC CANCER 
To achieve the complete resection of a mucosal gastric cancer with endoscopic resection, 
an accurate diagnosis of the extent of the tumor is required. By clearly visualizing the 
microvascular architecture and the microsurface structure inside and outside the lesion, 
magnifying NBI can distinguish the cancer margins from the surrounding benign 
mucosa, so it is expected to be useful for delineating the extent of a gastric tumor. In 
2004, Sumiyama et al. retrospectively described the feasibility of NBI for the guidance 
of en bloc endoscopic resection when combined with a multibending endoscope, but did 
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not perform a formal evaluation (47). Kadowaki et al. compared the utility of 
magnifying NBI and magnifying WLI in recognizing gastric cancer demarcation. They 
also reported that magnifying NBI is more useful when it is combined with acetic acid 
(48). Kiyotoki et al. (49) and Nagahama et al. (50) reported the superiority of 
magnifying NBI to chromoendoscopy for determining the lateral extent of early gastric 
cancer. These lines of evidence suggest that magnifying NBI can be a useful modality 
for determining the lateral extent of gastric cancer. However, it must be emphasized that 
it is still difficult to accurately define the tumor margin in undifferentiated gastric 
cancers; the successful delineation rate was 0% for undifferentiated cancers in one study 
(50). Because undifferentiated gastric cancers often spread subepithelially and are 
covered with nonneoplastic foveolar epithelium, observation of the mucosal surface by 
NBI is not useful for determining the tumor margin of this type of gastric cancer. 
Therefore, it is necessary to take biopsy specimens of the surrounding mucosa to define 
the extent of an otherwise undetectable tumor in undifferentiated gastric cancers. 
 
PREDICTION OF THE HISTOLOGICAL TYPE OF GASTRIC CANCER 
Nakayoshi et al. reported that the different microvascular patterns detected with 
magnifying NBI images are useful in predicting the histological type of a superficial 
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gastric cancer (51). Differentiated adenocarcinomas display a “fine network pattern,” 
and undifferentiated adenocarcinomas display a “corkscrew pattern” in their 
microvascular structures (Figure 2). Yoshida et al. reported that a “nonstructural pattern” 
appeared to be a useful marker of undifferentiated superficial gastric cancers (52).  
Although these studies have indicated the utility of magnifying NBI in the prediction of 
the histopathological type of a gastric cancer, its reliability must be validated in a 
large-scale prospective study. Moreover, even if magnifying NBI can predict the 
histological type of a cancerous lesion, histological confirmation by biopsy is required 
at this time. However, the prediction of histological type could be useful to the 
endoscopists when selecting the site of a biopsy in a lesion because gastric cancers are 
usually heterogeneous. 
 
DIAGNOSIS OF THE TUMOR DEPTH OF GASTRIC CANCER 
In contrast to ESCC, there is no evidence that NBI, with or without magnifying 
endoscopy, can predict the depth of tumor invasion in a patient with gastric cancer. 
 
DIAGNOSIS OF GASTRIC ADENOMA 
Because most gastric adenomas form protruded lesions, the differential diagnosis of 
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protruded gastric cancer and protruded adenoma is sometimes difficult (53, 54). Yao et 
al. reported that the characteristic finding of magnifying NBI, a white opaque substance 
(Figure 3), is a relevant sign for differentiating protruded adenomas from protruded 
cancers (55). Tsuji et al. also reported that the presence of an irregular microvascular 
pattern or irregular microsurface pattern with a demarcation line between the lesion and 
the surrounding area under magnifying NBI is useful in distinguishing cancers from 
adenomas (56). Maki et al. reported that magnifying NBI appears to be useful in 
differentiating between cancerous and adenomatous superficial elevated lesions of the 
stomach with significantly higher sensitivity and accuracy (57). In contrast, 
depressed-type adenoma is rare, although it is clinically important because it has greater 
malignant potential than protruded adenoma (58). Tamai et al. reported that 
depressed-type adenomas display a regular ultrafine pattern, in which the network of 
microvessels is composed of small and regular circles, which differs from the irregular 
fine network pattern of well-differentiated gastric cancers (59). 
These reports indicate that magnifying NBI should be a useful modality for the accurate 





Small duodenal ampullary tumors are treated by surgical resection or endoscopic 
resection. However, the lateral margin must be precisely assessed before curative 
endoscopic resection. Uchiyama et al. reported that magnifying NBI with a direct 
frontal-view magnifying endoscope can predict the histological characteristics of 
ampullary lesions by detecting abnormal vessels and microsurface patterns (60). Itoi et 
al. reported that NBI with a conventional duodenoscope, with no magnifying capacity, 
allowed better visualization of the tumor margin than indigo carmine chromoendoscopy 
(61). However, these studies included only a small number of cases, so further studies 
with a sufficient number of patients are required to evaluate the usefulness of NBI for 
duodenal tumors.  
 
Conclusion 
 NBI is now useful endoscopic modality for head and neck region and the upper 
gastrointestinal tract. It helps the endoscopists to do early detection and accurate 
diagnosis for the head and neck neoplasia and disease in the upper gastrointestinal 
diseases. Furthermore, it provides the many chance to do minimally invasive treatment 
and improves the patients’ survival and quality of life. Then, standard education 
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Table1  Advantage of NBI in contrast to WLI or CE in the clinical practice in the head and neck region and the upper gastrointestinal tract. 
 
NBI: narrow-band imaging; WLI: white light imaging; PPV: positive predictive value; NPV: negative predictive value; SIM: specialized intestinal 
metaplasia; HGD: high grade dysplasia; Sn.:sensitivity; Sp.: specificity; M-NBI: magnifying NBI; M-WLI: magnifying WLI; CE: chromoendoscopy; 




Figure 1. Superficial squamous cell carcinoma in the lower thoracic esophagus.  
(A) WLI shows scattered reddish spots in the slightly reddish area.  
(B) Lugol chromoendoscopy shows unstained area. 
(C) (D) NBI shows clearly defined brownish spots indicating dilated intrapapillary 
capillary loops. 
 
Figure 2. Microvascular patterns of gastric cancer. (A) Fine network pattern indicates 
differentiated adenocarcinoma. (B) Corkscrew pattern indicates undifferentiated 
adenocarcinoma. 
 
Figure 3. White opaque substance (WOS) within an elevated adenoma and 
well-differentiated adenocarcinoma. (A) The regular distribution of WOS indicates 
adenoma. (B) The irregular distribution of WOS indicates adenocarcinoma. 
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